Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depo-Medrol injection into mastectomy cavity to prevent seroma formation
2009-016650-40Phase 2Completed
- Sponsor
- Herlev Hospital
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of methylprednisolone in breast cancer and Seroma (2 arms), sponsored by Herlev Hospital. Primary endpoint: Seroma formation incidence. Started Mar 2010; status: completed.
02
Drugs
methylprednisolone
03
Conditions
breast cancerSeroma
Beyond the preview
Go deeper on 2009-016650-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016650-40.